Eric Nolen-Doerr, MD
Assistant Professor
Boston University Chobanian & Avedisian School of Medicine
Endocrinology, Diabetes, Nutrition & Weight Management

MD, Indiana University School of Medicine
BA, Miami University

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Kim DW, Kim E, Bertram K, Rim DS, Nolen-Doerr E, Shin JH. Long-term outcomes and adverse effects of teduglutide in patients with short bowel syndrome: Highlighting hyperamylasemia and hyperlipasemia. Am J Health Syst Pharm. 2024 Feb 08; 81(4):146-152. PMID: 37941451
  2. Tran T, Rim DS, Nolen-Doerr E, Lopez M, Nah Y, Sharma K, Shin JH, Kim DW. A Case of Abnormal Liver Function Tests in a Patient Receiving Total Parenteral Nutrition. J Investig Med High Impact Case Rep. 2023; 11:23247096231181969.View Related Profiles. PMID: 37357868; PMCID: PMC10331775; DOI: 10.1177/23247096231181969;
  3. Angelidi AM, Papadaki A, Nolen-Doerr E, Boutari C, Mantzoros CS. The effect of dietary patterns on non-alcoholic fatty liver disease diagnosed by biopsy or magnetic resonance in adults: a systematic review of randomised controlled trials. Metabolism. 2022 04; 129:155136.View Related Profiles. PMID: 35032545
  4. Papadaki A, Nolen-Doerr E, Mantzoros CS. The Effect of the Mediterranean Diet on Metabolic Health: A Systematic Review and Meta-Analysis of Controlled Trials in Adults. Nutrients. 2020 Oct 30; 12(11).View Related Profiles. PMID: 33143083; PMCID: PMC7692768; DOI: 10.3390/nu12113342;
  5. Nolen-Doerr E, Stockman MC, Rizo I. Mechanism of Glucagon-Like Peptide 1 Improvements in Type 2 Diabetes Mellitus and Obesity. Curr Obes Rep. 2019 Sep; 8(3):284-291.View Related Profiles. PMID: 31124035
  6. Farr OM, Upadhyay J, Rutagengwa C, DiPrisco B, Ranta Z, Adra A, Bapatla N, Douglas VP, Douglas KAA, Nolen-Doerr E, Mathew H, Mantzoros CS. Longer-term liraglutide administration at the highest dose approved for obesity increases reward-related orbitofrontal cortex activation in response to food cues: Implications for plateauing weight loss in response to anti-obesity therapies. Diabetes Obes Metab. 2019 11; 21(11):2459-2464.View Related Profiles. PMID: 31282006; PMCID: PMC6800581; DOI: 10.1111/dom.13827;
  7. Papathanasiou AE, Nolen-Doerr E, Farr OM, Mantzoros CS. GEOFFREY HARRIS PRIZE LECTURE 2018: Novel pathways regulating neuroendocrine function, energy homeostasis and metabolism in humans. Eur J Endocrinol. 2019 Feb 01; 180(2):R59-R71.View Related Profiles. PMID: 30475221; PMCID: PMC6378110; DOI: 10.1530/EJE-18-0847;
  8. Pilitsi E, Farr OM, Polyzos SA, Perakakis N, Nolen-Doerr E, Papathanasiou AE, Mantzoros CS. Pharmacotherapy of obesity: Available medications and drugs under investigation. Metabolism. 2019 03; 92:170-192.View Related Profiles. PMID: 30391259
  9. Nolen-Doerr E, Crick K, Saha C, de Groot M, Pillay Y, Shubrook JH, Donley D, Hornsby WG. Six-Minute Walk Test as a Predictive Measure of Exercise Capacity in Adults with Type 2 Diabetes. Cardiopulm Phys Ther J. 2018 Jul; 29(3):124-129. PMID: 31379471; PMCID: PMC6677537; DOI: 10.1097/CPT.0000000000000080;

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 9 publications over 6 distinct years, with a maximum of 3 publications in 2019


Contact for Mentoring:

75 E. Newton St
Boston MA 02118
Google Map

Nolen-Doerr's Networks
Click the "See All" links for more information and interactive visualizations
Similar People
Same Department